Human Insulin Market All Geared Up For Rapid Development With Expected Growth Of USD 43.6 Billion By 2021

05-Sep-2018 | Zion Market Research

With major players such as GlaxoSmithCline, Eli Lilly, Sanofi-Aventis, Biocon, Novo Nordisk, Julphar, Ypsomed AG, SemBioSys, and Wockhardt, the global human insulin market is set to expand in the years to come.

According to the analysts at Zion Market Research, the global human insulin market added up for USD 27.00 Billion in 2015 and is likely to cross USD 43.6 Billion by end of 2021, increasing at a CAGR of almost 8.3% from 2016 to 2021.

Request Sample Request Customization Buy Now

This review is based on a report by Zion Market Research, titled “Human Insulin Market by Product (Drug and Drug Delivery Devices) for Type 1 Diabetes, Type 2 Diabetes Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”- Report at http://www.zionmarketresearch.com/report/human-insulin-market

Increasing Risk Of Diabetes To Boost The Global Human Insulin Market

The global human insulin market is likely to see noteworthy development in the years to come. This development in global human insulin market is attributed owing to the rising market demand for human insulin analogs, increasing risk of diabetes, favorable medical reimbursements, and technological enactments in the field of human insulin delivery devices. An insulin routine is often needed in the treatment of gestational diabetes and diabetes related with specific syndromes or conditions (such as chemical or drug-induced diabetes, pancreatic diseases, insulin-receptor disorders, endocrinopathies, and specific genetic syndromes). In all cases of insulin employment, the dosage of insulin must be balanced and individualized with exercise and medical nutrition therapy, thereby boosting the global human insulin market.

Global Human nsulin Market

Increasing technical advancements is also one of the reasons for the growth of the global human insulin market. For instance, in June 2018, Eli Lilly and Company’s Humulin R U-500 (that was used in insulin pumps) displayed greater A1C lowering in adults suffering from type 2 diabetes. This was compared extraordinary in comparison to MDI (multiple daily injections), thereby driving the growth of global human insulin market.

Biosimilars Drugs Sector To Dominate The Of Global Human Insulin Market In The Near Future

Based on drugs, biosimilar drugs were likely to add up for the biggest market share of the global human insulin market and are expected to stay the same in the near future. Requirement for biosimilar drugs is sturdy in both developing and developed nations owing to its low-cost therapy. This is boosted by the requirement for the best valuable therapy, which can frequently be expensive. Biosimilar insulin drug might provide a less-pricy option to current human insulin biologics, thus boosting the global human insulin market.

Pens Will Rule The Drug Delivery Sector Of The Global Human Insulin Market In The Forecast Period

Based on drug delivery device, the pens section is likely to add up for the biggest share of global human insulin market followed by pen needle and syringe. This development can be attributed to increasing market aim of pen makers on up-and-coming nations such as India, China, and Brazil, thereby boosting the global human insulin market. Insulin pens seem similar to big ink pens, making them a possibly discreet and convenient way of carrying insulin. This makes up for one of the demanding factors for the development of global human insulin market.

The global human insulin market is segmented as follows:

By Type

  • Drugs
    • Insulin Analogs and Biosimilars
    • Human Insulin Biologics
  • Drug Delivery Devices
    • Pens
    • Pen Needles
    • Syringes

By Application

  • Insulin dependent diabetes mellitus (Type 1)
  • Non-Insulin dependent diabetes mellitus (Type 2)

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Download Brochure
Latest Published Reports

View All Published Reports